Ftse Mib
33.167,64
-0,78%
DAX
19.295,98
-0,59%
S&P 500
6.021,63
0,57%
NASDAQ
19.175,58
0,63%
Bitcoin
92.594,61
0,68%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ VYNE Therapeutics Inc (VYNE) VYNE Therapeutics Inc (VYNE) Notizie

VYNE Therapeutics Inc

VYNE
2,89
-0,06 (-2,03%)
27 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202421:34EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:06EDGAR2Form ARS - Annual Report to Security Holders
12/11/202422:01EDGAR2Form DEF 14A - Other definitive proxy statements
07/11/202422:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202414:03EDGAR2Form 8-K - Current report
02/10/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202414:01EDGAR2Form 8-K - Current report
14/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202414:04EDGAR2Form 8-K - Current report
04/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:00EDGAR2Form 8-K - Current report
01/3/202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
01/3/202423:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202414:12EDGAR2Form 8-K - Current report
02/2/202415:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/1/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202423:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202414:15EDGAR2Form 8-K - Current report
15/12/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/12/202322:00EDGAR2Form 8-K - Current report
04/12/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,95 Min: 2,77 Max: 2,95
Chiusura: 2,95

La tua Cronologia

NASDAQ
VYNE
VYNE Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network